PARP inhibitors are targeted drugs that block a DNA-repair pathway cancer cells rely on, especially in some BRCA-related cancers. They are used in several breast and ovarian settings.
These are not traditional chemo drugs, but they can still cause side effects like fatigue and blood-count changes, so regular monitoring is still important.